
Medicinova Provides Enrollment Update For Ongoing ALS And Hypertriglyceridemia Clinical Trials
(MENAFN- GlobeNewsWire - Nasdaq) MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients LA JOLLA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- MediciNova …